Indivior Pharmaceuticals Inc (NASDAQ:INDV) Q1 2026 Earnings Call Transcript April 30, 2026
Indivior Pharmaceuticals Inc beats earnings expectations. Reported EPS is $0.96, expectations were $0.64.
Operator: Good day, and thank you for standing by. Welcome to the Indivior Pharmaceuticals Q1 2026 Financial Results Conference Call and Webcast. [Operator Instructions] Please be advised that this conference is being recorded. I would now like to hand the conference over to our first speaker...
